InspireMD
NSPR
37 hedge funds and large institutions have $31.9M invested in InspireMD in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 8 closing their positions.
507% more capital inflows, than outflows
Capital inflows: $3.37M | Capital outflows: $554K
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
3% more funds holding
Funds holding: 36 → 37 (+1)
2.39% more ownership
Funds ownership: 43.53% → 45.93% (+2.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $8K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Soleus Capital Management
Greenwich,
Connecticut
|
+$2.34M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$311K |
| 3 |
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$159K |
| 4 |
Ironwood Investment Management
Boston,
Massachusetts
|
+$151K |
| 5 |
BlackRock
New York
|
+$91.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Essex Investment Management
Boston,
Massachusetts
|
-$195K |
| 2 |
Renaissance Technologies
New York
|
-$84.4K |
| 3 |
Dana Investment Advisors
Waukesha,
Wisconsin
|
-$80.9K |
| 4 |
Nottingham Advisors
Amherst,
New York
|
-$80.7K |
| 5 |
Legato Capital Management
San Francisco,
California
|
-$47.7K |
NSPR Hedge Fund Activity: Q2 2025 in Review
37 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q2 2025, worth a combined $31.9M — down 8.1% from $34.8M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NSPR positions and 8 closed out — a net gain of 1 holder — while 8 added to existing stakes and 0 trimmed.
The largest buyer was Soleus Capital Management, adding an estimated $2.34M. The largest seller was Essex Investment Management, exiting entirely with an estimated $195K sold.
- 37 institutional investors held InspireMD (NSPR) as of Q2 2025, up from 36 in Q1 2025.
- Funds reported $31.9M of InspireMD stock for Q2 2025, down 8.1% quarter-over-quarter.
- 9 funds opened new InspireMD positions in Q2 2025 and 8 closed out, a net change of +1 holder.
- The largest InspireMD buyer in Q2 2025 was Soleus Capital Management, an estimated $2.34M added.
- The largest InspireMD seller in Q2 2025 was Essex Investment Management, an estimated $195K sold.
Based on aggregated 13F filings for Q2 2025.